Chargement en cours...
Risk-adapted treatment reduced chemotherapy exposure for clinical stage I pediatric testicular cancer
BACKGROUND: Different from adult clinical stage I (CS1) testicular cancer, surveillance has been recommended for CS1 pediatric testicular cancer. However, among high-risk children, more than 50% suffer a relapse and progression during surveillance, and adjuvant chemotherapy needs to be administered....
Enregistré dans:
| Publié dans: | BMC Med Inform Decis Mak |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7737364/ https://ncbi.nlm.nih.gov/pubmed/33317510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12911-020-01365-x |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|